Clinical Trial Update: Efficacy and Safety of SR46349B in Patients With Sleep Disorders in Fibromyalgia [Phase 2]

View source ↗

Summary

This update reports the results of a Phase 2 study evaluating SR46349B for sleep disorders in patients with fibromyalgia, including efficacy and safety findings…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Fibromyalgia
• Sleep Disorders

Drugs mentioned

• SR46349B

Snippet

Sponsor: Sanofi | Conditions: Fibromyalgia, Sleep | Phase 2 | Status: COMPLETED